CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: dabigatran
Accession: CHEBI:70752
browse the term
Definition: An aromatic amide obtained by formal condensation of the carboxy group of 2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazole-5-carboxylic acid with the secondary amoino group of N-pyridin-2-yl-beta-alanine. The active metabolite of the prodrug dabigatran etexilate, it acts as an anticoagulant which is used for the prevention of stroke and systemic embolism.
Synonyms: related_synonym: Formula=C25H25N7O3; InChI=1S/C25H25N7O3/c1-31-20-10-7-17(25(35)32(13-11-23(33)34)21-4-2-3-12-28-21)14-19(20)30-22(31)15-29-18-8-5-16(6-9-18)24(26)27/h2-10,12,14,29H,11,13,15H2,1H3,(H3,26,27)(H,33,34); InChIKey=YBSJFWOBGCMAKL-UHFFFAOYSA-N; SMILES=Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1
xref: CAS:211914-51-1; KEGG:D09707
xref_mesh: MESH:D000069604
xref: PMID:21956605; PMID:22215856; PMID:22227958; PMID:22314599; PMID:22378612; PMID:22411291; PMID:22413715; PMID:22431533; PMID:22458575; PMID:22494098; PMID:22595629; PMID:22612026; PMID:22645678; PMID:22700854; PMID:22722043; PMID:22740145; PMID:22786838; PMID:22834159; PMID:22854367; PMID:23020832; PMID:23476049; Patent:US2006222640; Patent:US2008015176; Patent:US6087380; Patent:WO2004014894; Patent:WO2006004575; Patent:WO2006103206; Patent:WO2008009638; Patent:WO2008009639; Reaxys:9168207; Wikipedia:Dabigatran
G
Aif1
allograft inflammatory factor 1
decreases expression
ISO
Dabigatran results in decreased expression of AIF1 protein
CTD
PMID:27397090
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases expression
ISO
Dabigatran results in decreased expression of ALDH1A2 mRNA
CTD
PMID:31711903
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Eya1
EYA transcriptional coactivator and phosphatase 1
decreases expression
ISO
Dabigatran results in decreased expression of EYA1 mRNA
CTD
PMID:31711903
NCBI chr 5:4,863,501...5,101,483
Ensembl chr 5:4,955,543...5,101,483
G
F2
coagulation factor II
decreases activity
ISO
Dabigatran results in decreased activity of F2 protein
CTD
PMID:17911567 PMID:25138021
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fga
fibrinogen alpha chain
multiple interactions
ISO
Dabigatran inhibits the reaction [Dietary Fats results in increased cleavage of [FGA protein binds to FGB protein binds to FGG protein]]
CTD
PMID:25138021
NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
multiple interactions
ISO
Dabigatran inhibits the reaction [Dietary Fats results in increased cleavage of [FGA protein binds to FGB protein binds to FGG protein]]
CTD
PMID:25138021
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fgf8
fibroblast growth factor 8
increases expression
ISO
Dabigatran results in increased expression of FGF8 mRNA
CTD
PMID:31711903
NCBI chr 1:244,584,477...244,590,359
Ensembl chr 1:244,584,652...244,590,359
G
Fgg
fibrinogen gamma chain
multiple interactions
ISO
Dabigatran inhibits the reaction [Dietary Fats results in increased cleavage of [FGA protein binds to FGB protein binds to FGG protein]]
CTD
PMID:25138021
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Foxc2
forkhead box C2
decreases expression
ISO
Dabigatran results in decreased expression of FOXC2 mRNA
CTD
PMID:31711903
NCBI chr19:49,186,034...49,188,736
Ensembl chr19:49,185,662...49,188,737
G
Gdnf
glial cell derived neurotrophic factor
multiple interactions
EXP
Dabigatran inhibits the reaction [Rotenone results in decreased expression of GDNF mRNA]
CTD
PMID:28585189
NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209
G
Gfap
glial fibrillary acidic protein
decreases expression
ISO
Dabigatran results in decreased expression of GFAP protein
CTD
PMID:27397090
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Hoxb9
homeo box B9
increases expression
ISO
Dabigatran results in increased expression of HOXB9 mRNA
CTD
PMID:31711903
NCBI chr10:81,237,312...81,240,818
Ensembl chr10:81,237,312...81,240,818
G
Meox1
mesenchyme homeobox 1
decreases expression
ISO
Dabigatran results in decreased expression of MEOX1 mRNA
CTD
PMID:31711903
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
G
Mertk
MER proto-oncogene, tyrosine kinase
increases expression
ISO
Dabigatran results in increased expression of MERTK mRNA
CTD
PMID:27397090
NCBI chr 3:115,939,351...116,045,141
Ensembl chr 3:115,939,351...116,046,554
G
Neurog2
neurogenin 2
increases expression
ISO
Dabigatran results in increased expression of NEUROG2 mRNA
CTD
PMID:31711903
NCBI chr 2:216,092,641...216,095,276
Ensembl chr 2:216,093,363...216,094,154
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
multiple interactions
EXP
Dabigatran inhibits the reaction [Rotenone results in decreased expression of NR4A2 mRNA]
CTD
PMID:28585189
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Olig3
oligodendrocyte transcription factor 3
increases expression
ISO
Dabigatran results in increased expression of OLIG3 mRNA
CTD
PMID:31711903
NCBI chr 1:14,081,259...14,083,336
Ensembl chr 1:14,081,328...14,082,149
G
Pax3
paired box 3
decreases expression
ISO
Dabigatran results in decreased expression of PAX3 mRNA
CTD
PMID:31711903
NCBI chr 9:79,567,455...79,664,042
Ensembl chr 9:79,568,634...79,664,042
G
Pax6
paired box 6
increases expression
ISO
Dabigatran results in increased expression of PAX6 mRNA
CTD
PMID:31711903
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Plp1
proteolipid protein 1
increases expression
ISO
Dabigatran results in increased expression of PLP1 mRNA
CTD
PMID:27397090
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
G
Rcor2
REST corepressor 2
multiple interactions
EXP
Dabigatran inhibits the reaction [Rotenone results in decreased expression of RCOR2 mRNA]
CTD
PMID:28585189
NCBI chr 1:204,453,403...204,461,403
Ensembl chr 1:204,454,360...204,460,838
G
Ret
ret proto-oncogene
multiple interactions
EXP
Dabigatran inhibits the reaction [Rotenone results in decreased expression of RET protein]
CTD
PMID:28585189
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
G
Slc18a2
solute carrier family 18 member A2
multiple interactions
EXP
Dabigatran inhibits the reaction [Rotenone results in decreased expression of SLC18A2 mRNA]
CTD
PMID:28585189
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Snca
synuclein alpha
multiple interactions
EXP
Dabigatran inhibits the reaction [Rotenone results in increased expression of SNCA mRNA]
CTD
PMID:28585189
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Tcf15
transcription factor 15
decreases expression
ISO
Dabigatran results in decreased expression of TCF15 mRNA
CTD
PMID:31711903
NCBI chr 3:140,638,984...140,644,766
Ensembl chr 3:140,638,984...140,644,766
G
Th
tyrosine hydroxylase
multiple interactions
EXP
Dabigatran inhibits the reaction [Rotenone results in decreased expression of TH mRNA]
CTD
PMID:28585189
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tnf
tumor necrosis factor
multiple interactions
EXP
Dabigatran inhibits the reaction [Rotenone results in increased expression of TNF mRNA]
CTD
PMID:28585189
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Uncx
UNC homeobox
decreases expression
ISO
Dabigatran results in decreased expression of UNCX mRNA
CTD
PMID:31711903
NCBI chr12:15,092,779...15,097,300
Ensembl chr12:15,092,784...15,097,300
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all